These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3825179)

  • 1. The metabolism of [14C]N-ethoxycarbonyl-3-morpholinosydnonimine (molsidomine) in man.
    Wilson ID; Fromson JM; Illing HP; Schraven E
    Xenobiotica; 1987 Jan; 17(1):93-104. PubMed ID: 3825179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolism of [14C]N-ethoxycarbonyl-3-morpholinosydnonimine (molsidomine) in laboratory animals.
    Wilson ID; Watson KV; Troke J; Illing HP; Fromson JM
    Xenobiotica; 1986 Dec; 16(12):1117-28. PubMed ID: 3798959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver function and pharmacokinetics of molsidomine and its metabolite 3-morpholinosydnonimine in healthy volunteers.
    Wildgrube HJ; Ostrowski J; Chamberlain J; Gärtner W; Stockhausen H
    Arzneimittelforschung; 1986 Jul; 36(7):1129-33. PubMed ID: 3768083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and kinetics of amlodipine in man.
    Beresford AP; McGibney D; Humphrey MJ; Macrae PV; Stopher DA
    Xenobiotica; 1988 Feb; 18(2):245-54. PubMed ID: 2967593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of the anti-depressant lortalamine.
    Elsom LF; Biggs SR; Chasseaud LF; Hawkins DR; Pulsford J; Darragh A
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):209-15. PubMed ID: 4085522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of iloprost and cicaprost in mice.
    Hildebrand M
    Prostaglandins; 1992 Nov; 44(5):431-42. PubMed ID: 1281921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics and metabolism of 14C-carprofen in man.
    Ray JE; Wade DN
    Biopharm Drug Dispos; 1982; 3(1):29-38. PubMed ID: 7082777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The disposition and metabolic fate of 14C-cibenzoline in man.
    Massarella JW; Loh AC; Williams TH; Szuna AJ; Sandor D; Bressler R; Leinweber FJ
    Drug Metab Dispos; 1986; 14(1):59-64. PubMed ID: 2868867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite.
    Mihaly GW; Ward SA; Edwards G; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1984 Apr; 17(4):441-6. PubMed ID: 6721990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and pharmacokinetics of 14C-pentoxifylline in healthy volunteers.
    Bryce TA; Chamberlain J; Hillbeck D; Macdonald CM
    Arzneimittelforschung; 1989 Apr; 39(4):512-7. PubMed ID: 2751739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and pharmacokinetics of the dihydropyridine calcium antagonist, ryosidine, in man.
    Midgley I; Chasseaud LF; Taylor IW; Walmsley LM; Fowkes AG; Darragh A; Lambe RF; Bonn R
    Xenobiotica; 1985 Nov; 15(11):965-77. PubMed ID: 4082636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption and disposition of [14C]-molsidomine in laboratory animals.
    Fromson JM; Illing HP; Ings RM; Johnson KI; Johnson P; Ostrowski J; Schraven E; Steward A
    Arzneimittelforschung; 1981; 31(2):337-45. PubMed ID: 6894378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic and pharmacokinetic studies following oral administration of 14C-famciclovir to healthy subjects.
    Filer CW; Allen GD; Brown TA; Fowles SE; Hollis FJ; Mort EE; Prince WT; Ramji JV
    Xenobiotica; 1994 Apr; 24(4):357-68. PubMed ID: 8059539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of molsidomine in humans.
    Ostrowski J; Resag K
    Am Heart J; 1985 Mar; 109(3 Pt 2):641-3. PubMed ID: 3838399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man.
    Eckert HG; Badian MJ; Gantz D; Kellner HM; Volz M
    Arzneimittelforschung; 1984; 34(10B):1435-47. PubMed ID: 6097271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human pharmacokinetics of molsidomine].
    Singlas E; Martre H
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):503-9. PubMed ID: 6364946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition and biotransformation of the antipsychotic agent olanzapine in humans.
    Kassahun K; Mattiuz E; Nyhart E; Obermeyer B; Gillespie T; Murphy A; Goodwin RM; Tupper D; Callaghan JT; Lemberger L
    Drug Metab Dispos; 1997 Jan; 25(1):81-93. PubMed ID: 9010634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.